ARTICLE | Clinical News
PhotoCure reports Phase II Hexvix data
August 17, 2001 7:00 AM UTC
PhotoCure (OSE:PHO) said that its Hexvix fluorescence cystoscopy was superior to white light cystoscopy in diagnosing bladder cancer in a Phase II study of 52 patients with known or suspected bladder ...